Jörg Thomalla
- Neoadjuvant durvalumab improves survival in early triple-negative breast cancer independent of pathological complete response
2022/08/09 by S. Loibl, Sibylle Loibl, A. Schneeweiss +35 · 3 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Breast Cancer Treatment Studies #Cancer Immunotherapy and Biomarkers #HER2/EGFR in Cancer Research